NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response.
May 9, 2012
09:56
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr. Allison Goldfine is the head of the Section of Clinical Research at Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.B. Goldfine. Statins: Is It Really Time to Reassess Benefits and Risks? N Engl J Med 2012;366:1752-5.
NEJM Interviews